Luitpold Animal Health, manufacturers of Adequan IM, Adequan IA, and Adequan Canine, announced on Sept. 17 that a shipment of Adequan (polysulfated glycosaminoglycan) IM was released to the market last week and was received by veterinarians beginning Sept. 13.

Adequan product supply remains limited and the initial shipments will not fully satisfy market demand. Luitpold made significant investments in upgrading its manufacturing facilities earlier this year. The time spent making these upgrades impacted our ability to keep up with demand. “We are working diligently to release additional product to the market and will provide updates as they become available. Quality and integrity remain our highest priorities,” said the press release.

Adequan users should continue to work with their veterinarians to obtain the drug and discuss the most appropriate treatment regimen for their animals.

Luitpold has established a dedicated webpage where concerned parties can register to receive future communications and updates on this matter. They may also contact the Customer Service Department at 1-800-458-0163.